Monograph Details
|
|
Pain & Pyrexia
> Narcotic analgesics
|
|
NORCO 5/325 |
| Manufacturer |
|
Watson Pharmaceuticals, Inc. |
| Legal Classification |
|
CIII |
| Pharmacological Class |
|
Opioid + analgesic. |
| Generic Name |
|
Hydrocodone bitartrate 5mg, acetaminophen 325mg; scored tabs. |
| Also |
• NORCO 10/325
• NORCO 7.5/325
|
| Indications |
|
Moderate to moderately severe pain. |
| Children |
|
Not recommended. |
| Adults |
|
1–2 tabs every 4–6 hrs as needed. |
| Precautions |
|
Head injury. Increased intracranial pressure. Acute abdomen. Impaired renal, hepatic, thyroid, pulmonary, or adrenocortical function. GI or GU obstruction. Asthma. Drug abusers. Elderly. Debilitated. Labor & delivery. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Potentiation with alcohol, other CNS depressants, MAOIs, tricyclic antidepressants, antihistamines, anticholinergics, antipsychotics, antianxiety agents (reduce dose of either or both drugs if used together). Acetaminophen may cause false (+) urinary 5-hydroxyindoleacetic acid test. |
| Adverse Reactions |
|
Lightheadedness, CNS/respiratory depression, nausea, vomiting, constipation, urinary retention, rash, abuse potential; hepatotoxicity (overdosage). |
| How Supplied |
Tabs 5/325, 7.5/325—100
10/325—100, 500 |
|
|
|
|
